BIOMAT Database Logo BIOMAT Database Logo

[Obtaining anti-HLA typing sera by planned alloimmunization of volunteers (author's transl)]. 1978

D Hrubisková, and V Drobná, and M Kusíková

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D005260 Female Females
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

D Hrubisková, and V Drobná, and M Kusíková
Sera from volunteers immunized by planned blood transfusions as source of DR cytotoxic typing reagents.
January 1979, Immunological communications,
D Hrubisková, and V Drobná, and M Kusíková
[Some problems of HLA typing (author's transl)].
October 1978, Rinsho byori. The Japanese journal of clinical pathology,
D Hrubisková, and V Drobná, and M Kusíková
Sources of HLA typing sera.
January 1978, The Ulster medical journal,
D Hrubisková, and V Drobná, and M Kusíková
[Examination of sera from pregnant women for the presence of anti-HLA-DRw cytotoxins (author's transl)].
July 1980, Casopis lekaru ceskych,
D Hrubisková, and V Drobná, and M Kusíková
[Method of obtaining anti-Rh sera].
July 1975, Problemy gematologii i perelivaniia krovi,
D Hrubisková, and V Drobná, and M Kusíková
[Methodology for HLA typing of amniotic fluid fetal cells (author's transl)].
January 1980, Annales de genetique,
D Hrubisková, and V Drobná, and M Kusíková
[Immunology of the pustular bacterid of Andrews. II. HLA-typing (author's transl)].
May 1980, Dermatologische Monatschrift,
D Hrubisková, and V Drobná, and M Kusíková
[Artificial immunization of volunteers with allogeneic leukocytes for the purpose of obtaining anti-HL-A sera].
December 1977, Problemy gematologii i perelivaniia krovi,
D Hrubisková, and V Drobná, and M Kusíková
[Characteristics of anti-HLA immunization in pregnancy (author's transl)].
January 1982, Sangre,
D Hrubisková, and V Drobná, and M Kusíková
Nomenclature of the rhesus typing sera (transl.).
January 1949, Bulletin of the World Health Organization,
Copied contents to your clipboard!